Vikas Chandrawanshi has been appointed as Assistant General Manager / Group Lead at Intas Pharmaceuticals, marking a significant milestone in his accomplished career in upstream process development and biosimilar research. Based in Ahmedabad, he now leads critical initiatives in cell culture, biosimilars, and scale-up activities, bringing deep scientific expertise and hands-on operational experience to one of India’s leading pharmaceutical organizations.
Prior to joining Intas, Vikas made notable contributions at Dr. Reddy’s Laboratories, where he served for over six years in key roles within the Cell Culture division. As Scientist & Team Lead, he guided teams of 6–14 researchers working on Fed-batch and ATF-based upstream process development, spanning AMBR to 1KL single-use bioreactor scales. His extensive experience across 10 monoclonal antibodies, successful scale-up of three biosimilars, and execution of advanced studies like FMEA, DOE, and process characterization positioned him as a strategic scientific leader in the biosimilar development space. His earlier role as Research Associate further strengthened his expertise in operating advanced bioreactors, cell banking, cGxP compliance, and contributing to scale-up of two major biosimilars.
Vikas also brings valuable research exposure from the Indian Institute of Technology, Bombay, where he served as Assistant Project Manager and Research Associate on DBT-funded diagnostic device development and CHO cell–based bioprocess studies. His four-year tenure as a Teaching Assistant across multiple engineering and bioprocess labs reflects his strong academic foundation and ability to mentor future researchers while managing critical laboratory operations including HPLC facility oversight.
His journey in the field began with a hands-on technical foundation as a Technical Trainee in Cell Culture Manufacturing at Dr. Reddy’s, giving him early exposure to industrial cell culture workflows and bioprocess principles. Over the years, Vikas has also earned recognition through specialized training, presentations, and digital learning programs, showcasing his commitment to continuous improvement and scientific growth.
With this new appointment at Intas Pharmaceuticals, Vikas Chandrawanshi is set to strengthen upstream process innovation, enhance biosimilar development efficiency, and drive impactful scientific outcomes. His rich blend of academic excellence, industry leadership, and deep technical capabilities positions him as a valuable addition to the organization’s mission of advancing high-quality, affordable biologics.